| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Caribou Biosciences, Inc. serves as a 10% Owner at NTLA. Across recent SEC filings that breaks down to 0 buys and 2 sells. Those positions are worth an estimated $48.2M at current prices.
The biggest single holding is NTLA (~$48.2M) as 10% Owner. The recent filings there lean toward selling, a net 1,599,491 shares.